找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Management of Macular Hemorrhage; Lars-Olof Hattenbach Book 2018 Springer International Publishing AG, part of Springer Nature 2018 Anti-V

[復(fù)制鏈接]
查看: 7288|回復(fù): 42
樓主
發(fā)表于 2025-3-21 16:16:09 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Management of Macular Hemorrhage
編輯Lars-Olof Hattenbach
視頻videohttp://file.papertrans.cn/623/622540/622540.mp4
概述Systematic overview of therapeutic approaches to macular hemorrhage under various conditions.Full coverage of risk factors, diagnostic aspects, and prognostic criteria.Informative case presentations a
圖書封面Titlebook: Management of Macular Hemorrhage;  Lars-Olof Hattenbach Book 2018 Springer International Publishing AG, part of Springer Nature 2018 Anti-V
描述.Sub- or preretinal hemorrhage involving the macula is a typical complication in a variety of ocular diseases, including age-related macular degeneration, arterial macroaneurysm, Valsalva retinopathy, and trauma. However, there is currently no consensus regarding the ideal treatment for macular hemorrhage..The purpose of this book on macular hemorrhage is twofold: it aims both to impart valuable information on pathophysiology, risk factors, diagnostic aspects, and prognostic criteria under different conditions and to provide a systematic overview of therapeutic approaches that cover the most important situations a vitreoretinal surgeon might encounter when treating patients with this disorder. Case presentations, clinical photographs, and an extensive review of the literature supplement the important information on clinical decision making, surgical techniques, and typical pitfalls and invite the reader to explore the advantages and disadvantages of various approaches to the management of macular hemorrhage..
出版日期Book 2018
關(guān)鍵詞Anti-VEGF Agents; Minimally Invasive Surgery; Risk Factors; Sub RPE; Subretinal Hemorrhage
版次1
doihttps://doi.org/10.1007/978-3-319-65877-3
isbn_softcover978-3-030-09754-7
isbn_ebook978-3-319-65877-3
copyrightSpringer International Publishing AG, part of Springer Nature 2018
The information of publication is updating

書目名稱Management of Macular Hemorrhage影響因子(影響力)




書目名稱Management of Macular Hemorrhage影響因子(影響力)學(xué)科排名




書目名稱Management of Macular Hemorrhage網(wǎng)絡(luò)公開度




書目名稱Management of Macular Hemorrhage網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Management of Macular Hemorrhage被引頻次




書目名稱Management of Macular Hemorrhage被引頻次學(xué)科排名




書目名稱Management of Macular Hemorrhage年度引用




書目名稱Management of Macular Hemorrhage年度引用學(xué)科排名




書目名稱Management of Macular Hemorrhage讀者反饋




書目名稱Management of Macular Hemorrhage讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:19:21 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:03:26 | 只看該作者
地板
發(fā)表于 2025-3-22 05:33:29 | 只看該作者
5#
發(fā)表于 2025-3-22 11:40:41 | 只看該作者
Macular Haemorrhages: Natural Course and Risk Factors,Subretinal haemorrhage is a rare but serious complication that occurs in conjunction with macular diseases. The most common cause is choroidal neovascularisation (CNV) in the eyes with age-related macular degeneration (AMD). In some series, more than 80% of patients with submacular haemorrhage had underlying AMD [1, 2].
6#
發(fā)表于 2025-3-22 15:03:36 | 只看該作者
Macular Translocation,Since its introduction intravitreal anti-VEGF therapy (ranibizumab, bevacizumab) for neovascular age-related macular degeneration has improved the therapeutical options and outcomes for patients with neovascular age-related macular degeneration [1–4].
7#
發(fā)表于 2025-3-22 20:50:35 | 只看該作者
The Pathophysiology of Subretinal Hemorrhage,oroidal or retinal circulation or both. Different pathological entities affecting these circulatory systems as well as trauma may be the cause of SRH. Independently from the underlying trigger, SRH damages tissue through a variety of mechanisms: The presence of iron, hemosiderin, and fibrin in the b
8#
發(fā)表于 2025-3-22 23:50:36 | 只看該作者
Classification of Macular Hemorrhages,the underlying pathology, commonly a choroidal neovascular membrane (CNVM), especially in AMD patients, followed by non-AMD-related CNVM and retinal arterial macroaneurysms (RAM) and (2) the extent and location of the hemorrhage including size, thickness, and location in relation to the fovea and th
9#
發(fā)表于 2025-3-23 04:22:12 | 只看該作者
Subretinal Co-application of rtPA and Bevacizumab for Neovascular AMD with Submacular Hemorrhage,a macular scar with poor visual function is the usual outcome. While several surgical treatment approaches have been proposed to date, there is no general consensus regarding optimal treatment of acute SMH. Vitrectomy with subretinal co-application of recombinant tissue plasminogen activator (rtPA)
10#
發(fā)表于 2025-3-23 07:52:54 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 05:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
高雄县| 吉安县| 宝坻区| 甘泉县| 平原县| 黎城县| 庆云县| 竹北市| 黄山市| 盱眙县| 绥中县| 精河县| 延吉市| 运城市| 南和县| 毕节市| 富顺县| 南靖县| 库车县| 象州县| 舟山市| 日土县| 漳浦县| 宜宾市| 吴江市| 柳州市| 朝阳市| 东源县| 乌海市| 丽水市| 南昌县| 巩义市| 都江堰市| 韶山市| 轮台县| 海南省| 成都市| 牟定县| 汶上县| 满洲里市| 兴化市|